Novacyt S.A. (ALNOV) is an international biotechnology company focused on the development, manufacturing, and distribution of diagnostic tests and reagents. The company specializes in molecular diagnostics, including tests for the detection of infectious diseases and genetic mutations. Novacyt plays a crucial role in the diagnostic industry, providing tools for rapid and accurate identification of various pathogens. Their technologies are utilized in healthcare, research, and other sectors. Novacyt S.A. focuses on innovation and the development of new diagnostic solutions. Investors interested in the biotechnology sector and healthcare innovations might see potential in Novacyt S.A. (ALNOV) shares for growth in this pivotal field.